Dr. Syreeta L. Tilghman will serve on the Mechanisms of Cancer Therapeutics NIH Study Section
12 Jul

Dr. Syreeta L. Tilghman will serve on the Mechanisms of Cancer Therapeutics NIH Study Section

Florida A&M College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health (CoPPS, IPH) professor, Dr. Syreeta L. Tilghman, has been invited to serve on the Mechanisms of Cancer Therapeutics National Institutes of Health (NIH) study section.   

Membership in an NIH study section represents a significant achievement, commitment of professional time and energy, and a unique opportunity to contribute to the national biomedical research effort.  She was nominated to serve on this panel because of her demonstrated competence and achievement in breast cancer research, as evidenced by the quality of her research accomplishments, publications in scientific journals, and other significant scientific activities, achievements, and honors.  Service on this panel requires mature judgment and objectivity as the ability to work effectively in a group.  

“Being appointed to serve as a standing member of an NIH study section panel is a prestigious honor that will provide national recognition and honor to FAMU and the College,” said Associate Dean of Pharmaceutical Sciences, Dr. Selina Darling-Reed. 

Dr. Tilghman was selected on May 4, 2021, and will begin her term on July 01, 2021, and end on June 30, 2027.   

About the Author